These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 405291)

  • 21. [Treatment of chronic arterial occlusive disease of the lower limbs with propionyl-1-carnitine in elderly patients].
    Terranova R; Luca S
    Minerva Med; 2001 Feb; 92(1):61-6. PubMed ID: 11317141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
    Goebel KM; Neitzert A
    Ther Umsch; 1975 Jun; 32(6):350-6. PubMed ID: 806127
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J; Spaan G; Stein U; Wagner E; Frese JH
    Med Klin; 1979 Sep; 74(39):1396-403. PubMed ID: 492058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostanoids in therapy of peripheral arterial occlusive disease.
    Creutzig A; Caspary L
    Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effective therapy of chronic arterial circulatory disorders with Nico-Padutin forte (author's transl)].
    Vorberg G
    MMW Munch Med Wochenschr; 1976 Oct; 118(44):1429-32. PubMed ID: 825753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 30. Classification of peripheral occlusive arterial diseases based on symptoms, signs and distal blood pressure measurements.
    Tønnesen KH; Noer I; Paaske W; Sager P
    Acta Chir Scand; 1980; 146(2):101-4. PubMed ID: 7415745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of peripheral vascular diseases with dihydroergocristine].
    Moracchini PV; Alfano G; Melandri F
    Minerva Cardioangiol; 1978 Apr; 26(4):277-90. PubMed ID: 97601
    [No Abstract]   [Full Text] [Related]  

  • 33. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease].
    Diehm C; Mörl H; Schettler G
    Z Kardiol; 1983 Jan; 72(1):44-7. PubMed ID: 6837085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term results of the treatment of arteritis with intra-arterial injections using Reboul's technique].
    Van der Molen HR; Toth LM; Collard JJ; Balmus KJ
    Phlebologie; 1979; 32(1):57-65. PubMed ID: 432291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
    Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative plethysmographic study of the venoconstrictor effect of dihydroergotamine and dihydroergotoxine on the deep veins of the calf in healthy subjects and patients suffering from varicosis.
    Barthel W; Grossmann K
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):458-64. PubMed ID: 7141753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.